RA0439

antibody from Oursmab
Targeting: KDR CD309, FLK1, VEGFR, VEGFR2
Provider product page for RA0439
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0439 - Provider product page
Provider
Oursmab
Product name
Ramucirumab (Biosimilar Reference Antibody) (KDR)
Antibody type
Monoclonal
Description
Ramucirumab is a fully human IgG1 monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR-2). It blocks the binding of VEGF ligands to VEGFR-2, inhibiting angiogenesis (new blood vessel formation) and thereby starving tumors of oxygen and nutrients. It is approved for the treatment of advanced gastric, colorectal, lung, and hepatocellular cancers.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
KDR protein structure - RA0439 shown in red.